Propranolol in Schizophrenia
- 1 August 1981
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 139 (2) , 105-111
- https://doi.org/10.1192/bjp.139.2.105
Abstract
Summary: Fifty-three hospitalized chronic schizophrenic patients were treated with either propranolol, chlorpromazine or placebo in a double-blind randomized trial for up to three months. Propranolol in a usual dose of 640 mg/day, produced marked cardiovascular effects but no improvement in schizophrenic symptomatology relative to placebo. The effects of chlorpromazine were small and inconsistent.This publication has 29 references indexed in Scilit:
- DL‐propranolol and chlorpromazine following admission for schizophreniaActa Psychiatrica Scandinavica, 1981
- Propranolol in Chronic Schizophrenia: A Controlled Study in Neuroleptic-Treated PatientsThe British Journal of Psychiatry, 1980
- Two patients with schizophrenic-like psychosis after treatment with beta-adrenergic blockers.BMJ, 1979
- Effect of tolamolol and other β-adrenoceptor blocking drugs on [3H]haloperidol binding to rat striatal membrane preparationsJournal of Pharmacy and Pharmacology, 1978
- PROPRANOLOL IN SCHIZOPHRENIAThe Lancet, 1977
- PROPRANOLOL IN SCHIZOPHRENIAThe Lancet, 1977
- Propranolol PsychosisThe British Journal of Psychiatry, 1976
- Withdrawal of maintenance drugs with long-term hospitalized mental patients: A critical review.Psychological Bulletin, 1974
- Chlorpromazine and the Untreated Chronic Schizophrenic: A Long-Term TrialThe British Journal of Psychiatry, 1967
- An Appraisal of the Continuing Practice of Prescribing Tranquillizing Drugs for Long-stay Psychiatric PatientsThe British Journal of Psychiatry, 1967